123I-BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients
NCT ID: NCT00586950
Last Updated: 2011-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2006-06-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diffusion Weighted Magnetic Resonance Imaging in Chronic Kidney Disease
NCT03174899
Multimodal Imaging Assessment of Chronic Kidney Disease Patients at Different Stages From a Cardio-Renal Interaction Perspective
NCT07107919
Ultra Low Iodine Loaded Spectral CT Angiography (CTA)
NCT05488899
MRI Assessment of Myocardial Fibrosis Associated With Monocyte Phenotype in End Stage Renal Failure
NCT03857633
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
NCT03586518
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes mellitus
* Hyperlipidemia
* Obliterative arteriosclerosis in the lower extremities
* Smoker
* Family history of juvenile coronary artery disease
* History of ischemic stroke
* History of heart failure requiring hospitalization
* Within 3 months after initiation of hemodialysis therapy
* Dialysis hypotension
Exclusion Criteria
* Severe valvular disorder requiring treatment
* Diagnosis of hypertrophic cardiomyopathy(HCM) or dilated cardiomyopathy(DCM) before start of dialysis
* History of revascularization(PCI, CABG) or prior diagnosis of myocardial infarction
* Hypersensitivity to BMIPP or its analogue
* Judged unsuitable for the study for any other reasons by physicians.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Toho University Ohashi Medical Center
UNKNOWN
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hokkaido Cardiovascular Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenjiro Kikuchi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Asahikawa Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toho University Ohashi Medical Center
Meguro-ku, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHA_CAD05-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.